Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity

Not Recruiting

Trial ID: NCT01203436

Age - N/A-48 Hours Gender - All Accepting Healthy Volunteers - No

Purpose

The purpose of this trial was to determine the efficacy and safety of supplemental therapeutic oxygen for infants with prethreshold retinopathy of prematurity (ROP) to reduce the probability of progression to threshold ROP and the need for peripheral retinal ablation.

Official Title

Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity

Stanford Investigator(s)

David K. Stevenson, M.D.

Eligibility


Inclusion Criteria:

   - Infants with prethreshold retinopathy of prematurity, confirmed by 2 certified
   ophthalmologic exams

   - Median pulse oxygen saturation <94% in room air

   - Median pulse oxygen saturation can be kept safely >96% on oxygen/ventilator

Exclusion Criteria:

   - No fatal congenital anomaly or congenital eye anomaly

View More
View Less

Intervention(s):

procedure: Supplemental Oxygen Management

procedure: Conventional Oxygen Management

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

©2022 Stanford Medicine